Aphria Inc. announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma...
Medical device company, REVA Medical has announced the geographic expansion of its commercial operations in seven Europe...
Sandoz Inc., a Novartis division, and Pear Therapeutics has announced the US commercial launch of reSET-O(TM) for patien...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Medidata has announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its sen...
Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has grante...
Generex Biotechnology Corporation has announced that the company has completed the acquisition of 51% of Regentys Corpor...
MYnd Analytics, a predictive analytics company aimed at improving the delivery of mental health services through the com...
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...
Stemedica Cell Technologies announced positive results from its Phase I/IIa clinical study for the treatment of ischemic...
Eli Lilly and Loxo Oncology, have announced a definitive agreement for Lilly to acquire Loxo Oncol...
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced Project ALPHA (Analytics fo...
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...
Green Leaf Medical, LLC, a MSO (Multi-State Operator) of medical cannabis facilities in the Northeast United S...
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...
Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...
